May 20, 2015
Cadwalader, Wickersham & Taft LLP, a leading counselor to global financial institutions and corporations, announced that Dr. Dorothy Auth, a partner in the firm’s New York office, has been officially installed as president of the New York Intellectual Property Law Association. She will serve a one-year term.
The New York Intellectual Property Law Association (NYIPLA) is a bar association comprising lawyers interested in patent, trademark and copyright law who live or work in the jurisdictions of the U.S. Court of Appeals for the Second Circuit, namely New York, Connecticut and Vermont, and the District of New Jersey. Established in 1922, NYIPLA promotes the development and administration of intellectual property and related laws, and provides its membership with opportunities to make their views known and to advance the knowledge of legal professionals, the judiciary, government and the public.
Dr. Auth has more than 20 years of experience in complex patent litigation, as well as licensing, patent procurement, and intellectual property counseling in the United States and abroad. Her experience spans a range of industries, including biotechnology, pharmaceutical, and medical devices, as well as consumer products, computers, and other mechanical devices. Her clients include Salix Pharmaceuticals, Pfizer and Healthcare Royalty Partners. Dr. Auth also litigates in U.S. Federal courts and international arbitrations conducted under the WIPO rules, and has represented Medinol, National Institutes of Health, Anheiser-Busch and Credit Suisse, among others.
At Cadwalader, Dr. Auth is a member of the Technology Committee, the Healthcare Industry Team and the Advisory Counsel for the firm’s Center for Career Advancement. Dr. Auth also served as the Partner Chair of the Women’s Leadership Initiative for five years.
She earned her J.D. from St. John's School of Law, a Ph.D. in biochemistry from Tufts Medical School, and her B.A. in biochemistry from Cook College of Rutgers University.
Howard Hawkins, Mark Ellenberg, Michele Maman, Thomas Curtin, Elizabeth Ruocco
Scott Cammarn, Jonathan Watkins, Mark Chorazak, Aaron Lang
On 7 June 2019, Regulation (EU) 2019/876 (CRR II) was published in the Official Journal of the EU.